Correction: UBS Maintains Buy on Teradyne, Raises Price Target to $500
Benzinga Newsdesk 3 months ago
NewsPrice TargetAnalyst Ratings
Correction: UBS analyst Timothy Arcuri maintains Teradyne (NASDAQ:TER) with a Buy and raises the price target from $440 to $500.
Correction: UBS analyst Timothy Arcuri maintains Teradyne (NASDAQ:TER) with a Buy and raises the price target from $440 to $500.